Within the minimum time window This should go without saying, but do not inject within 48 hours (semaglutide) or 72 hours (tirzepatide) of your last dose under any circumstances
Comprehensive Support for GLP-1 Therapy Manage Side Effects & Maximize Weight Loss
Compounded semaglutide products are not reviewed or approved by the FDA for safety, effectiveness, or manufacturing consistency, and some formulations may involve different ingredients, concentrations, or semaglutide salts that differ from Novo Nordisks approved medications
It showed that the relative risks for aspiration, aspiration pneumonia, pneumonia, or respiratory failure were not elevated in patients prescribed GLP-1 RA compared to those receiving dipeptidylpeptidase-4 (DPP-4) inhibitors [21]
Stop and contact your doctor immediately if you experience severe abdominal pain, signs of dehydration, vomiting that lasts more than 24 hours, or any symptoms that interfere significantly with daily life